Primary sclerosing mucoepidermoid carcinoma with eosinophilia (SMECE) of the thyroid gland is a very rare disease. We present the clinical and histopathologic findings of a 37-year-old woman recently diagnosed with SMECE of the thyroid gland. The patient, clinically euthyroid, who presented with a neck swelling since last 2 years along. Fine needle aspiration cytology suggested thyroid papillary carcinoma. Total thyroidectomy, central neck dissection and right selective neck dissection were performed. Although SMECE is considered to be a relatively slow growing and non-aggressive tumor, occasional metastasis does occur. We report an additional case of SMECE, with metastasis to regional lymph nodes. Physicians should be aware of extended operation, including total thyroidectomy and/or neck node dissection for metastatic lesion of the neck node. More standardized treatment is likely to evolve in the future.
Introduction
Sclerosing mucoepidermoid carcinoma with eosinophilia (SMECE) of the thyroid gland was first described by Chan et al. 1) in 1991 as a new distinctive low-grade carcinoma of the thyroid gland generally occurring in the background of Hashimoto's thyroiditis. Since this initial report, another 21 additional cases have been described in the literature as small case studies and as individual case reports. SMECE tends to affect women between the ages of 32 and 74. 1) In contrast; conventional mucoepidermoid carcinoma (MEC) of the thyroid gland affects a slightly younger age group and may affect men (2:1). 2) Most SMECE cases manifested a relatively indolent clinical course despite significant contiguous adenopathy and soft-tissue extension of the tumor. Metastasis has been described as an unusual manifestation of this new clinical entity. 3, 4) Because of the rarity of SMECE, definitive management remains elusive. We report a case of a 37-year-old woman who was diagnosed with SMECE in the setting of lymphocytic thyroiditis and treated surgically with total thyroidectomy and right selective neck dissection. The purpose of this paper is to present a case, review the pertinent literature, and provide insights into treatment options. Neck computed tomography also showed a right thyroid mass and metastatic right supraclavicular lymph node (Fig. 1) . A positron emission tomography (PET) scan didn't show any distant metastatic disease; however, the suspicious metastatic uptake was seen in the right supraclavicular lymph nodes ( Fig. 2 ).
In October 2012, the patient underwent total thyroidectomy and right selective neck node dissection. She 
Discussion
MEC is a rare primary thyroid tumor with indolent MEC is usually a malignancy of the salivary glands, although it has been reported in other locations. [5] [6] [7] [8] [9] [10] In 1991, Chan et al. The most common presenting symptom is a painless neck mass or cold nodule on thyroid scan. 19) Symptoms secondary to locoregional extension such as hoarseness have been described. The average age of patients in the literature was 54 years with the majority of the patients being women. 19) The first man to be reported with SMECE was in a case series of 3 patients reported by Wenig et al. 14) in which the patient was unfortunately lost to follow-up after having surgery. The second male patient reported by Geisinger et al. 3) had spine and liver metastasis.
Generally, the SMECE can behave in a slowly growing manner and even in the presence of extension outside the thyroid gland can be associated with prolonged survival. This tumor tends to involve the adjacent perithyroidal tissues extensively including adipose tissue and skeletal muscles. In some cases it may extend more widely into the larynx, 15) trachea, 1, 4, 16, 20) and esophagus. 1, 4, 15, 20) Although the growth of this tumor is usually slow, Chan et al. 1) and
subsequently Geisinger et al. 3) described 2 cases of rapidly growing tumors. Rare cases of lung and other distant metastases are reported. 3, 4, 20) The eosinophilia, which is an important diagnostic clue to this lesion, remains unexplained, but it is likely that the tumor produces a cytokine that serves as a chemoattractant to eosinophils. 1, 3, 4, 15, 16, 21) Whether this feature is responsible for the indolent behaviour of this lesion even in cases with extrathyroidal extension remains to be determined.
A limited number of cases preclude definitive recommendations regarding the proper treatment of MEC.
The treatment that has been described in all cases varied from thyroid lobectomy to total thyroidectomy with modified radical neck dissection in addition to radiotherapy, chemotherapy, and iodine ablation. 1, 3, 4, 14, 16, 17) Most of the patients in the Chan et al. 1) Concurrent chemoradiotherapy was not used in the cases that were described in this review; however, our patient showed very good response in the majority of the areas that were irradiated with concurrent carboplatin.
In conclusion, SMECE appears to be a uniquely distinct disease with especially aggressive behaviour as in our case, having noncontiguous multiple lymph nodes and visceral metastasis. SMECE is biologically aggressive as our case shows by virtue not merely of its local lymph node metastatic pattern but the involvement of noncontiguous lymph nodes, progressive local soft-tissue involvement, and distant visceral metastatic sites. Because this has significant prognostic implications, we believe this entity is biologically unique requiring accurate pathologic classification. More standardized treatment is likely to evolve in the future, with current management of patients with SMECE being surgical. Treatment of metastatic disease is certainly not well defined; however, with more familiarity with this neoplasm, this may well change.
